Platform
Features
0 followers
TenSixteen Bio is the first company to leverage somatic mosaicism and clonal hematopoiesis of indeterminate potential (CHIP) to discover and develop novel therapeutics to treat age-related diseases.
Industries
Headquarters
Employees
Links
2 members
Cargo
1 follower
Apogee Therapeutics
Imvax
Elektrofi
Cellares
2 followers
Thermo Fisher Scientific
149 followers
Gilead Sciences
121 followers
Biogen
108 followers
Regeneron
89 followers
Akari Therapeutics
Vertex Pharmaceuticals
50 followers
Discover companies